ADACH , K. Lipid-altering efficacy of ezetimibe/simvastatin 10/20 mg compared with rosuvastatin 10 mg in high risk hypercholesterolaemic patients inadequately controlled with prior statin monotherapy. Medycyna Faktow (J EBM), v. 3, n. 1(6), p. 16-29, 13 Apr. 2010.